BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs4950928
,
KLK3
,
Response to oxidative stress
,
Arthritis
,
Retina
,
Pharmacogenetics
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
map erk kinase kinase 1
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Ras, MKK3, and MKK7 targeted MAP Kinase activation in mouse heart
Hepatic expression signatures affected in p14 knockout mice
Lungs from Mek1 and Mek2 knockout embryos
Embryonic fibroblasts from DUSP5 knockout mice treated in culture with phorbol ester TPA
Gastrointestinal stromal tumor GIST882 cells with COP1 siRNA knockdown and treated with PD0325901
Explore Curated Studies Results
Literature
Most Relevant Literature
MAP3K1 regulates female reproductive tract development.
The combined effects of Map3k1 mutation and dioxin on differentiation of keratinocytes derived from …
Circulating miR-320b Contributes to CD4+ T-Cell Proliferation in Systemic Lupus Erythematosus via MA…
Whole exome sequencing identifies MAP3K1, MSH2, and MLH1 as potential cancer-predisposing genes in f…
Genetic Control of MAP3K1 in Eye Development and Sex Differentiation.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Evaluation of a Promising New Combination of Protein Kinase Inhibitors on Organotypic Cultures of Hu…
Randomized Phase II Study of AZD6244 (Mitogen-activated Protein Kinase Inhibitor) MEK-Inhibitor With…
Expression of EPK in Recurrent Miscarriage
Lorlatinib Combinations in Lung Cancer
Encorafenib + Binimetinib + Pembrolizumab in Patients With Unresectable or Metastatic BRAF V600 Muta…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ